Prescription Audits: When the DEA or AG Come Knocking
Anticipating and Responding to Heightened Investigations of Prescribing and Dispensing Practices
A live 90-minute CLE webinar with interactive Q&A
This CLE webinar will discuss the increased scrutiny of healthcare providers’ prescribing and dispensing practices by the Drug Enforcement Administration (DEA) and state attorneys general (AG) through their medical boards and other actions, and will guide counsel in preparing for and responding to prescription audits and ensuring ongoing regulatory compliance.
- Current trends in prescribing and dispensing enforcement
- Audit process
- State AG
- Audit preparedness
- Maintaining records
- Policies and procedures
- Risk issues
- Responding to an audit
The panel will review these and other crucial issues:
- What should providers and counsel expect when the DEA or state AG conducts a prescription audit?
- What policies and procedures should be in place to ensure compliance with federal regulations?
- What are best practices for counsel to providers facing a DEA or state AG audit?
Lee H. Rosebush
A registered patent attorney and registered pharmacist, Mr. Rosebush focuses his practice on FDA, regulatory,... | Read More
A registered patent attorney and registered pharmacist, Mr. Rosebush focuses his practice on FDA, regulatory, compliance and enforcement issues pertaining to pharmaceuticals, biologics and medical devices. He assists clients with healthcare-related issues stemming from Medicare, Medicaid and state regulatory requirements. He advises clients in matters relating to FDA regulatory compliance, including governance in the drug naming process, clinical trial, marketing, promotion and advertisement and approval process.Close
to be announced.
Buy Live Webinar
Includes Early Discount Savings of $50 (through 07/27/18)
Buy Live Webinar & Recording
Includes special savings of $250 (through 07/27/18)
Live Webinar & Download
Live Webinar & DVD
$344 + $9.45 S&H